Neonatal Jaundice: Knowledge, Attitudes & Practices of Mothers & Medical

Status Completed

Clinical Trial Summary

Determine the knowledge attitude and practices of all levels of health care providers about neonatal jaundice

Clinical Trial Description

During the routine post-natal visit, trained research personnel will inform the mother of the infant or medical practitioner that a study in being carried out to better understand the knowledge, attitudes and practices of mothers and health care providers for neonatal jaundice. The investigators will then proceed to ask the mothers or health care professionals if they would be interested in filling out an anonymous survey that will assess their knowledge of neonatal jaundice and their practices, if any, in caring for this condition. No PHI will be included and no written consent will be obtained as the written consent would be the only link to the person participating in the survey. Verbal consent will be obtained and we will explain that their medical care and care of the children will in no way be affected by their answers to the survey. We will carefully explain that their participation in the survey is voluntary.

For medical students, they will be informed that a study is being carried out to better understand the knowledge, attitudes and practices of medical trainees for neonatal jaundice. They will then be asked if they would be interested in filling out an anonymous survey that assess their knowledge of neonatal jaundice, and their practices, if any, in caring for this condition. No PHI will be included and no written consent will be obtained, as the written consent would be the only link to the person participating in the survey. Verbal consent will be obtained and we will explain that their academic standing will not be affected by their answers to the survey. We will carefully explain that their participation in the survey is voluntary.

All surveys will contain the names and contact information of the investigators.

The survey will be administered under the direction of the researchers by the researchers and/or their trained research team. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03306004
Study type	Observational
Source	University of Minnesota - Clinical and Translational Science Institute
Contact
Status	Completed
Phase	N/A
Start date	November 2016
Completion date	December 31, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04365998` - BUBOLight®, a New Phototherapy Device for the Treatment of the Newborn's Jaundice	N/A
Completed	`NCT02222805` - Effect of Timing of Umbilical Cord Clamping on Anaemia at 8 and 12 Months and Later Neurodevelopment	N/A
Completed	`NCT01622699` - Implementation of a Transcutaneous Bilirubinometer	N/A
Completed	`NCT00692224` - Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized Trial	Phase 1/Phase 2
Not yet recruiting	`NCT06080971` - Persistent Neonatal Jaundice on Neonates and Childern
Recruiting	`NCT06075290` - the Difference of Follow-up Methods of Neonatal Jaundice
Recruiting	`NCT05955144` - Clinical Validation of the Screening Tool Picterus JP Using Different Smartphones	N/A
Recruiting	`NCT05127070` - Evaluating the NeoTree in Malawi and Zimbabwe
Completed	`NCT02774434` - Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age	N/A
Terminated	`NCT05365399` - Evaluation of a Smartphone-based Screening Tool for Neonatal Jaundice in a Ugandan Population	N/A
Recruiting	`NCT03933423` - Home Based Phototherapy for Neonatal Jaundice	N/A
Recruiting	`NCT03183986` - Comparison of the Efficacy of Phototherapy Using Blue LED's With Wavelength 478 vs. 459 nm.	N/A
Withdrawn	`NCT00917007` - Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
Completed	`NCT06227624` - Role of Oral Zinc in Reducing Neonatal Indirect Hyperbilirubinemia	Phase 3
Completed	`NCT04418180` - Fenofibrate Therapy in Pathological Unconjugated Hyperbilirubinemia in Full Term Infants	N/A
Completed	`NCT04433923` - Aluminium Foil as an Adjuvant to Phototherapy for Pathological Unconjugated Hyperbilirubinaemia in Full Term Infants	N/A
Not yet recruiting	`NCT05475223` - End Tidal Carbon Monoxide (ETCO): - A Tool to Aid Identification of Neonatal Hemolysis	N/A
Recruiting	`NCT03237715` - Unbound Bilirubin Levels in Healthy Term and Late Preterm Infants	N/A
Terminated	`NCT03055481` - A Trial of the Irradiance Level of Phototherapy for Neonatal Jaundice	N/A
Recruiting	`NCT05521607` - Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Neonatal Jaundice: Knowledge, Attitudes and Practices of Mothers and Medical Trainees and Providers in and Around Ogbomosho — 4NNJ

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms